Press Releases from Mitre Medical Corp. (5 total)
Mitre Medical Corp.: Mitre Medical Corp, is proud to be an Exhibitor at the upco …
Silicon Valley, March 29, 2019 – Mitre Medical Corp. announces the participation the STS Workshop on Robotic Cardiac Surgery in Atlanta, Georgia. The course will offer extensive hands-on procedural experience in a state-of-the-art robotics training facility. Specially designed for surgical teams, the event will put participants in a realistic, cardiac robotics simulation environment where they can hone their skills in mitral valve repair, coronary bypass, and other cardiac surgery procedures.
“We…
Mitre Medical Corp. Clinical Data to be Presented Today at EACTS, Including the …
Silicon Valley, October 18, 2018 – The clinical experience with the first 5 Mitral Touch implants enrolled in the ENRAPT MR Trial will be presented today at the EACTS Conference in Milan, Italy. Prof. Dr. med. Klaus Kallenbach of HaerzZenter Luxembourg will also provide the first formal presentation of the Mitral Touch Sizers, a pair of surgical tools that complement the procedure and provide surgeons with their first tool…
Mitre Medical Corp.: Mitre Medical Corp. Strengthens Its Team with New Strategic …
Silicon Valley, April 17, 2018 – Mitre Medical Corp. announces successful recruitment of experienced cardiac surgery business executive Maria Sainz as a Strategic Advisor. Ms. Sainz brings more than two decades of medical device industry experience most recently as President and CEO of CardioKinetix. Notable among prior senior leadership roles, she served as President of Guidant’s Cardiac Surgery Division from 2003 through 2006 and as CEO of Concentric Medical.
“We are…
Mitre Medical Corp.: Completion of the feasibility phase for the Mitral Touch® …
Silicon Valley, 03/28/2018 – Mitre Medical Corp. announces completion of the feasibility phase of the Study of the Mitral Touch System for the Reduction of Mitral Valve Regurgitation (the EnraptMR Trial). Treatment with the Mitral Touch implant has demonstrated safety and technical success including durability of MR reduction at 30 days.
“Validation of durable MR reduction on the beating hearts of these challenging patients is a real milestone for…
Mitre Medical Corp. announces the initial clinical trial enrollment for beating …
This less invasive procedure offers an alternative approach to mitigate moderate to severe mitral regurgitation.
Silicon Valley, 01/26/2018 - Mitre Medical Corp. announces the initial enrollment of patients treated with the Mitral Touch epicardial annuloplasty device. The procedures were performed by cardiac surgeons Kestutis Rucinskas, M.D., Ph.D. and Gintaras Kalinauskas, M.D. of Vilnius University Hospital Santaros Klinikos, Cardiac Surgery Center in Vilnius, Lithuania.
The Mitral Touch is an epicardial, less-invasive surgical…
